Issue 1/2014
Content (7 Articles)
Leading Article
EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars
Begoña Calvo, Leyre Zuñiga
Systematic Review
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
Ursula Reichenpfader, Gerald Gartlehner, Laura C. Morgan, Amy Greenblatt, Barbara Nussbaumer, Richard A. Hansen, Megan Van Noord, Linda Lux, Bradley N. Gaynes
Review Article
Post-Approval Evaluation of Effectiveness of Risk Minimisation: Methods, Challenges and Interpretation
Anjan Kumar Banerjee, Inge M. Zomerdijk, Stella Wooder, Simon Ingate, Stephen J. Mayall
Original Research Article
Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law
Xin Shen, Zheng’an Yuan, Jian Mei, Zurong Zhang, Juntao Guo, Zheyuan Wu, Jie Wu, Haihua Zhang, Jieping Pan, Wenming Huang, Huili Gong, Dong Yuan, Ping Xiao, Yanqin Wang, Yi Shuai, Senlin Lin, Qichao Pan, Tong Zhou, Paul B. Watkins, Fan Wu
Original Research Article
Comparing Time to Adverse Drug Reaction Signals in a Spontaneous Reporting Database and a Claims Database: A Case Study of Rofecoxib-Induced Myocardial Infarction and Rosiglitazone-Induced Heart Failure Signals in Australia
Izyan A.Wahab, Nicole L. Pratt, Lisa M. Kalisch, Elizabeth E. Roughead
Open Access
Original Research Article
vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues
Tomas Bergvall, G. Niklas Norén, Marie Lindquist